Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M40.6Revenue $M31.5Net Margin (%)-27.6Altman Z-Score-8.9
Enterprise Value $M0.6EPS $-0.6Operating Margin %-27.4Piotroski F-Score2
P/E(ttm)--Beneish M-Score-1.6Pre-tax Margin (%)-27.6Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio5.5Cash flow > EarningsN
Price/Sales1.35-y EBITDA Growth Rate %--Current Ratio5.5Lower Leverage y-yY
Price/Free Cash Flow68.8y-y EBITDA Growth Rate %-243.6ROA % (ttm)-16.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-23.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M14.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARDM

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARDMFirst Eagle Investment 2014-06-30 Buy 0.08%$0.185 - $9.52
($3.37)
$ 2.75-18%New holding3,854,730
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARDM is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ARDM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
THOMPSON VIRGILDirector 2013-12-13Sell84$6.8-59.56view
Grifols SADirector, 10% Owner 2013-08-27Sell0$0-59.56view
Boxer Capital, LLC10% Owner 2013-05-20Sell0$0-59.56view
DEF Associates Ltd.See footnote below 2012-01-01Sell0$0-59.56view
DEF Associates LPSee Footnote 1 below 2010-12-31Sell0$0-59.56view
First Eagle Value in BiotechnoSee remarks. 2009-02-23Sell0$0-59.56view
First Eagle Value in Biotechno10% Owner 2009-02-23Sell0$0-59.56view
Grimes D JefferyVP Legal Affairs, Secretary 2008-07-01Sell0$0-59.56view
RA Capital Biotech Fund II, L.10% Owner 2007-03-01Sell0$0-59.56view
TANG KEVIN C10% Owner 2007-01-25Sell0$0-59.56view

Quarterly/Annual Reports about ARDM:

    News about ARDM:

    Articles On GuruFocus.com
    Supernus Pharmaceuticals Reports Insider Buys Mar 26 2013 
    Eveillard’s First Eagle Seizes 45% of Pharamaceutical Company, Aradigm Dec 19 2012 

    More From Other Websites
    Aradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2016... Feb 02 2016
    Aradigm to Host Corporate Update Conference Call on January 6 Jan 05 2016
    Aradigm to Host Corporate Update Conference Call on January 6 Jan 05 2016
    Aradigm Corp.: Sudden move in price, will it continue? Dec 23 2015
    Aradigm Corp. Earnings Analysis: Q3, 2015 By the Numbers Dec 21 2015
    ARADIGM CORP Financials Dec 08 2015
    How it All Plays Out - Research on Aradigm, Ideal Power, CareDx, and Colony Bankcorp Dec 03 2015
    ARADIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 12 2015
    ARADIGM CORP Files SEC form 10-Q, Quarterly Report Nov 12 2015
    Aradigm Announces Third Quarter 2015 Financial Results Nov 11 2015
    Aradigm reports 3Q loss Nov 11 2015
    Aradigm reports 3Q loss Nov 11 2015
    Aradigm Announces Third Quarter 2015 Financial Results Nov 11 2015
    Aradigm Corp. – Value Analysis (NASDAQ:ARDM) : October 30, 2015 Oct 30 2015
    Aradigm Corporation Completes Enrollment in the Second Phase III Study of Pulmaquin in Non-Cystic... Oct 13 2015
    Aradigm to Present at the Ladenburg Thalmann 2015 Healthcare Conference on September 29 Sep 23 2015
    Aradigm to Present at the Ladenburg Thalmann 2015 Healthcare Conference on September 29 Sep 23 2015
    Aradigm Corporation Completes Enrollment in Phase III Study of Pulmaquin in Non-Cystic Fibrosis... Sep 22 2015
    Aradigm Corporation Completes Enrollment in Phase III Study of Pulmaquin in Non-Cystic Fibrosis... Sep 22 2015
    Results from Pulmonary Non-Tuberculous Mycobacteria (PNTM) Study Using Aradigm's Liposomal... Sep 10 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK